help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slatore, C. G.
Right arrow Articles by White, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slatore, C. G.
Right arrow Articles by White, E.
American Journal of Respiratory and Critical Care Medicine Vol 178. pp. 653-654, (2008)
© 2008 American Thoracic Society


Correspondence

Can Moderate Doses of Vitamin E Protect against Lung Cancer?

From the Authors:

We appreciate Dr. Dembe's comments on our article regarding a possible U-shaped association between 10-year use of supplemental vitamin E and lung cancer when this relationship was examined categorically according to low, medium, and high doses (1). As there was little information about a dose–response relationship between supplemental vitamin E and lung cancer risk, we a priori elected to divide dose levels according to the distribution of use in the cohort. Post hoc analyses performed to enhance any association would have been inappropriate. In addition, the most commonly sold dose of vitamin E is 400 mg (dl {alpha}-tocopheryl acetate). Therefore, study participants in the medium category may have been more likely to have consumed vitamin E supplements for shorter durations (e.g., 400 mg/d for 5 yr) than to have taken lower dose pills (e.g., 200 mg/d for 10 yr).

We agree with Dr. Dembe that our findings suggest a possible U-shaped association between long-term supplemental vitamin E and lung cancer risk and that additional research needs to be done to confirm this association. We hope that our work, along with that of Miller and colleagues (2), may prove useful to future researchers in exploring the dose- and duration-specific association between supplemental vitamin E and lung cancer risk and mortality.

Christopher G. Slatore

University of Washington
Seattle, Washington

David H. Au

VA Puget Sound Health Care System
and
University of Washington
Seattle, Washington

Emily White

University of Washington
and
Fred Hutchinson Cancer Research Center
Seattle, Washington

FOOTNOTES

Conflict of Interest Statement: None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

REFERENCES

  1. Slatore CG, Littman AJ, Au DH, Satia JA, White E. Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med 2008;177:524–530.[Abstract/Free Full Text]
  2. Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142:37–46.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slatore, C. G.
Right arrow Articles by White, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slatore, C. G.
Right arrow Articles by White, E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society